| Name | Androgen receptor antagonist 4 |
|---|
| Description | Androgen receptor antagonist 4 (Compound AT2) is an androgen receptor (AR) antagonist with an IC50 of 0.15 μM. Androgen receptor antagonist 4 efficiently antagonizes AR transcriptional activity, suppresses downstream target gene of AR, and blocks the DHT-induced AR nuclear translocation. Androgen receptor antagonist 4 shows anticancer activities[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.15 μM (Androgen receptor)[1] |
| References |
| Molecular Formula | C22H18ClN |
|---|---|
| Molecular Weight | 331.84 |